Amphastar Pharmaceuticals, Inc. (AMPH)
25.43
+0.08
(+0.32%)
USD |
NASDAQ |
Oct 02, 16:00
25.44
+0.01
(+0.04%)
After-Hours: 20:00
Amphastar Pharmaceuticals Shareholders Equity (Quarterly) : 768.16M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 768.16M |
| March 31, 2026 | 773.39M |
| December 31, 2025 | 788.80M |
| September 30, 2025 | 776.75M |
| June 30, 2025 | 757.48M |
| March 31, 2025 | 751.28M |
| December 31, 2024 | 732.30M |
| September 30, 2024 | 727.68M |
| June 30, 2024 | 713.35M |
| March 31, 2024 | 672.36M |
| December 31, 2023 | 639.42M |
| September 30, 2023 | 595.14M |
| June 30, 2023 | 589.24M |
| March 31, 2023 | 548.58M |
| December 31, 2022 | 528.66M |
| September 30, 2022 | 505.16M |
| June 30, 2022 | 499.31M |
| March 31, 2022 | 479.52M |
| December 31, 2021 | 445.52M |
| September 30, 2021 | 430.18M |
| June 30, 2021 | 421.99M |
| March 31, 2021 | 405.56M |
| December 31, 2020 | 402.31M |
| September 30, 2020 | 405.23M |
| June 30, 2020 | 397.68M |
| Date | Value |
|---|---|
| March 31, 2020 | 377.51M |
| December 31, 2019 | 381.37M |
| September 30, 2019 | 389.40M |
| June 30, 2019 | 387.84M |
| March 31, 2019 | 334.99M |
| December 31, 2018 | 332.44M |
| September 30, 2018 | 319.42M |
| June 30, 2018 | 320.53M |
| March 31, 2018 | 327.10M |
| December 31, 2017 | 333.74M |
| September 30, 2017 | 330.66M |
| June 30, 2017 | 333.31M |
| March 31, 2017 | 325.56M |
| December 31, 2016 | 329.26M |
| September 30, 2016 | 328.45M |
| June 30, 2016 | 307.46M |
| March 31, 2016 | 296.58M |
| December 31, 2015 | 295.51M |
| September 30, 2015 | 283.79M |
| June 30, 2015 | 285.26M |
| March 31, 2015 | 279.28M |
| December 31, 2014 | 281.86M |
| September 30, 2014 | 283.12M |
| June 30, 2014 | 287.74M |
| March 31, 2014 | 251.54M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Viatris, Inc. | 14.26B |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
| Merck & Co., Inc. | 41.93B |
| Pfizer Inc. | 85.19B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.744B |
| Total Liabilities (Quarterly) | 975.61M |
| Debt to Equity Ratio | 0.8961 |
| Current Ratio | 2.397 |
| Net Debt Paydown Yield | -0.83% |